Mechanisms of the triglyceride- and cholesterol-lowering effect of fenofibrate in hyperlipidemic type 2 diabetic patients

Diabetes

Volumn 51, Issue 12, 2002, Pages 3486-3491

  Forcheron, Fabien ^a   Cachefo, Ana ^a   Thevenon, Sylvie ^a   Pinteur, Claudie ^a   Beylot, Michel ^a,b  

^a INSERM   (France)

^b EDOUARD HERRIOT HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; FENOFIBRATE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; LOW DENSITY LIPOPROTEIN RECEPTOR; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN; MESSENGER RNA; SCAVENGER RECEPTOR; TRIACYLGLYCEROL;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; COMORBIDITY; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HUMAN; HYPERLIPIDEMIA; LIPOPROTEIN BLOOD LEVEL; MALE; MONONUCLEAR CELL; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0036894367     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.51.12.3486     Document Type: Article

References (46)

1. Gervois P, Torra I, Fruchart J, Staels B: Regulation of lipid and lipoprotein metabolism by PPAR activators. Clin Chem Lab Med 38:3-11, 2000
2. Auboeuf D, Rieusset J, Fajas L, Vallier P, Frering V, Riou JP, Staels B, Auwerx J, Laville M, Vidal H: Tissue distribution and quantification of the expression of mRNAs of peroxisome proliferator-activated receptors and liver X receptor-α in humans: No alteration in adipose tissue of obese and NIDDM patients. Diabetes 46:1319-1327, 1997
3. Su J, Simmons C, Wisely B, Ellis B, Winegar D: Monitoring of PPAR alpha protein expression in human tissue by the use of PPAR alpha specific MAbs. Hybridoma 17:47-53, 1998
4. Gbaguidi F, Chinetti G, Milosavljevic D, Teissier E, Chapman J, Olivecrona G, Fruchart JC, Griglio S, Fruchart-Najib J, Staels B: Peroxisome proliferator-activated receptor (PPAR) agonists decrease lipoprotein lipase secretion and glycated LDL uptake by human macrophages. FEBS Lett 512:85-90, 2002
5. Jones D, Ding X, Daynes R: Nuclear receptor peroxisome proliferator-activated receptor alpha is expressed in resting murine lymphocytes. J Biol Chem 277:6838-6845, 2002
6. Staels B, Dallongeville J, Auwerx J, Schoonjans K, Leitersdorf E, Fruchart, J: Mechanism of action of fibrates on lipid and lipoprotein metabolism. Circulation 98:2088-2093, 1998
7. Heller F, Harvengt C: Effects of clofibrate, bezafibrate, fenofibrate and probucol on plasma lipolytic enzymes in normolipidaemic subjects. Eur J Clin Pharmacol 23:57-63, 1983
8. Zhang Y, Repa J, Gauthier K, Mangelsdorf D: Regulation of lipoprotein lipase by the oxysterol receptors LXR alpha and LXR beta. J Biol Chem 276:43018-43024, 2001
9. Malmendier C, Lontie J, Delcroix C, Dubois D, Magot T, De Roy L: Apolipoproteins C-II and C-III metabolism in hypertryglyceridemic patients: Effect of a drastic triglyceride reduction by combined diet restriction and fenofibrate administration. Atherosclerosis 77:139-149, 1989
10. Fruchart J: Peroxisome proliferator-activated receptor alpha activation and high-density lipoprotein metabolism. Am J Cardiol 88 (Suppl.):24N-29N, 2001
11. Chinetti G, Gbaguidi F, Griglio S, Mallat Z, Antonucci M, Poumlain P, Chapman J, Fruchart JC, Tedgui A, Najib-Fruchart J, Staels B: CLA-1/SR-BI is expressed in atherosclerotic lesion macrophages and regulated by activators of peroxisome proliferator-activated receptors. Circulation 101:2411-2417, 2000
12. Chinetti G, Lestavel S, Bocher V, Remaley AT, Neve B, Torra IP, Teissier E, Minnich A, Jaye M, Duverger N, Brewer HB, Fruchart JC, Clavet V, Staels B: PPAR-alpha and PPAR-gamma activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway. Nat Med 7:53-58, 2001
13. Trigatti B, Rigotti A, Braun A: Cellular and physiological roles of SR-BI, a lipoprotein receptor which mediates selective lipid uptake. Biochim Biophys Acta 1529:276-286, 2000
14. Young S, Fielding C: The ABC's of cholesterol efflux. Nat Genet 22:316-318, 1999
15. Guo Q, Wang P, Milot D, Ippolito M, Hernandez M, Burton CA, Wright SD, Chao Y: Regulation of lipid metabolism and gene expression by fenofibrate in hamsters. Biochim Biophys Acta 1533:220-232, 2001
16. Faix D, Neese R, Kletke C, Wolden S, Cesar S, Countlangus M, Shackleton M, Hellerstein M: Quantification of menstrual and diurnal periodocities in rates of cholesterol and fat synthesis in humans. L Lipid Res 34:2063-2075, 1993
17. Beylot M, Riou JP, Bienvenu F, Momex R: Increased ketonaemia in hyperthyroidism: Evidence for a beta-adrenergic mechanism. Diabetologia 19:505-510, 1980
18. Vidon C, Boucher P, Cachefo A, Peroni O, Diraison F, Beylot M: Effects of isoenergetic high-carbohydrate compared with high-fat diets on human cholesterol synthesis and expression of key genes of cholesterol metabolism. Am J Clin Nutr 73:878-884, 2001
19. Cachefo A, Boucher P, Vidon C, Dusserre E, Diraison F, Beylot M: Hepatic lipogenesis and cholesterol synthesis in hyperthyroid patients. J Clin Endocrinol Metab 86:5353-5357, 2001
20. Folch J, Lees M, Sloane-Stanley GH: A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem 226:497-509, 1957
21. Diraison F, Pachiaudi C, Beylot M: Measuring lipogenesis and cholesterol synthesis in humans with deuterated water: Use of simple gas chromatography mass spectrometry techniques. J Mass Spectrom 32:81-86, 1997
22. Morrison WR, Smith L: Preparation of fatty acid methyl esters and dimethylacetals from lipids with boron fluoride-methanol. J Lipid Res 5:600-608, 1964
23. Diraison F, Beylot M: Role of human liver lipogenesis and reesterification in triglycerides secretion and in FFA reesterification. Am J Physiol 274:E321-E327, 1998
24. Yang D, Diraison F, Beylot M, Brunegraber DZ, Samols MA, Anderson VE, Brunenbraber H: Assay of low deuterium enrichment of water by isotopic exchange with [U-13C]acetone and gas chromatography mass spectrometry. Anal Biochem 258:315-321, 1998
25. Boyum A: Isolation of mononuclear cells and granulocytes from human blood: Isolation of mononuclear cells by one centrifugation and of granulcytes by combining centrifugation and sedimentation at 1g. Scand J Clin Lab Invest 21 (Suppl. 97):77-89, 1968
26. Boucher P, Lorgeril M, Salen P, Crozier P, Delaye J, Vallon JJ, Geyssant A, Dante R: Effects of dietary cholesterol on LDL-receptor, HMG-CoA reductase and LDL receptor-related protein (LRP) mRNA expression in healthy humans. Lipids 33:1177-1186, 1998
27. Auboeuf D, Vidal H: The use of reverse transcription competitive polymerase chain reaction to investigate the in vivo regulation of gene expression in small tissue samples. Anal Biochem 245:141-148, 1997
28. Diraison F, Pachiaudi C, Beylot M: In vivo determination of plasma cholesterol and fatty acids synthesis with deuterated water: determination of the average number of deuterium incorporated. Metab Clin Exp 45:817-821, 1996
29. Goodman DS, Smith FR, Seplowitz AH, Ramakrishnan R, Dell RB: Prediction of parameters of whole body cholesterol metabolism in humans. J Lipid Res 21:699-713, 1980
30. Daghers JF, Lyons JH, Finlayson DC, Shamsai J, Moore FD: Blood volume measurement: A critical study. Adv Surg 1:69-109, 1965
31. Lewis G, Uffelman K, Szeto L, Weller B, Steiner G: Interaction between free fatty acids and insulin in the acute control of VLDL production in humans. J Clin Invest 96:135-140, 1995
32. McGarry JD, Foster D: Regulation of hepatic fatty acids oxidation and ketone body production. Annu Rev Biochem 49:395-420, 1980
33. Hagenfeldt L, Wahren J, Pemon B, Rof L: Uptake of individual free fatty acids by skeletal muscle and liver in man. J Clin Invest 51:2324-2330, 1972
34. D'Costa M, Angel A: Inhibition of hormone stimulated lipolysis by clofibrate: A possible mechanism for its hypolipidemic action. J Clin Invest 55:138-148, 1975
35. Schoonjans K, Staels B, Auwerx J: Role of the peroxisome proliferator-activated receptor (PPAR) in mediating the effects of fibrates and fatty acids on gene expression. J Lipid Res 37:907-925, 1996
36. Minnich A, Tian N, Byan L, Bilder G: A potent PPAR alpha agonist stimulates mitochondrial fatty acid beta-oxidation in liver and skeletal muscles. Am J Physiol 280:E270-E279, 2001
37. Muoio D, Way J, Tanner C, Winegar DA, Kliewer SA, Houmard JA, Kraus WE, Dohm GL: Peroxisome proliferator-activated receptor-α regulates fatty acid utilization in primary human skeletal muscle cells. Diabetes 51:901-909, 2002
38. Dietschy JM, McGarry JD: Limitations of acetate as a substrate for measuring cholesterol synthesis in liver. J Biol Chem 249:52-58, 1974
39. Powell E, Kroon P: LDL receptor and HMGCoA-reductase gene expression in human mononuclear leukocytes is regulated coordinately and parallels gene expression in liver. J Clin Invest 93:2168-2174, 1994
40. Tobin K, Steineger H, Alberti S, Spydevold O, Auwerx J, Gustafsson JA, Nebb HI: Cross-talk between fatty acid and cholesterol metabolism mediated by liver X receptor alpha. Molecular Endocrinology 14:741-752, 2000
41. Costet P, Luo Y, Wang N, Tall A: Sterol-dependent transactivation of the ABC1 promoter by the liver X receptor/retinoid X receptor. J Biol Chem 275:28240-28245, 2000
42. Schwartz K, Lawn R, Wade D: ABC1 gene expression and ApoA-I-mediated cholesterol efflux are regulated by LXR. Biochem Biophys Res Commun 274:794-802, 2000
43. Venkateswaran A, Laffitte B, Joseph S, Mak PA, Wilpitz DC, Edwards PA, Tontonoz P: Control of cellular cholesterol efflux by the nuclear oxysterol receptor LXR alpha. Proc Natl Acad Sci U S A 97:12097-12102, 2000
44. Luo Y, Liang C, Tall A: The orphan nuclear receptor LRH-1 potentiates the sterol-mediated induction of the human CETP gene by liver X receptor. J Biol Chem 276:24767-27773, 2001
45. Bouly M, Masson D, Gross B, Jiang XC, Fievet C, Castro G, Tall A, Fruchart JC, Staels B, Lagrost L Luc G: Induction of phospholipid transfer protein gene accounts for the high density lipoprotein enlargement in mice treated with fenofibrate. J Biol Chem 276:25841-25847, 2001
46. Joseph S, Lafotte B, Patel P, Watson MA, Matsukuma KE, Walczak R, Collins JL, Osborne TF, Tontonoz P: Direct and indirect mechanisms for regulation of fatty acid synthase expression by liver X receptors. J Biol Chem 277:11019-11025, 2002